views
After wrapping up the Indian leg of action-thriller Citadel, actress Samantha Ruth is planning to take a one-year hiatus from acting. During this time, she aims to prioritise her health and seek treatment for her autoimmune condition, Myositis, in the United States.
Addressing the reports of her returning money to producers for the projects she had signed, a source told Hindustan Times, “This is a bit of assumption and exaggeration because she decided to take a break some time ago and was not even accepting anything. There is no new project where her name was associated with.”
Samantha revealed in 2022 that she has an autoimmune condition called Myositis. She took a six-month break for treatment at that time, and now she is focused on regaining her health before returning to work. “She is taking a break as she wants to focus on her health. She just came back because of her commitments. She was in mid of shooting of Kushi when she fell ill. Now, she has to go for the main treatment and therapy session,” shares the source.
According to the source, the 36-year-old actress will be traveling to the United States in August for a minimum one-year break. The reason for her break is her ongoing battle with an autoimmune disease, which requires extensive treatment and therapy sessions. She plans to seek treatment in the US and may also visit South Korea for medical purposes.
Despite being known for her workaholic nature, Samantha is eagerly awaiting her break. She believes it is essential for her overall well-being and aims to prioritise her recovery in a holistic manner. While speaking about her decision, Samantha talked about her enthusiasm for the break. “It is something which she wants for her well-being. She wants to get better in a more holistic way. When I spoke to her about her decision, she confessed that she is looking forward to the break. Unless her health is fully recovered, it will be difficult for her to resume work and continue acting which is a demanding job. She knows that due to which she is happy about the break,” the source ends.
Comments
0 comment